山东中医药大学学报2024,Vol.48Issue(2) :246-253.DOI:10.16294/j.cnki.1007-659x.2024.02.019

黄酮类中药单体干预Nrf2/HO-1通路治疗糖尿病微血管并发症研究进展

Research Progress of Flavonoid Monomer in Treating Diabetic Microangiopathy by Regulating Nrf2/HO-1 Signaling Pathway

刘映君 阴永辉 王文宽 张金涛 孔畅
山东中医药大学学报2024,Vol.48Issue(2) :246-253.DOI:10.16294/j.cnki.1007-659x.2024.02.019

黄酮类中药单体干预Nrf2/HO-1通路治疗糖尿病微血管并发症研究进展

Research Progress of Flavonoid Monomer in Treating Diabetic Microangiopathy by Regulating Nrf2/HO-1 Signaling Pathway

刘映君 1阴永辉 2王文宽 1张金涛 1孔畅1
扫码查看

作者信息

  • 1. 山东中医药大学,山东济南 250355
  • 2. 山东中医药大学附属医院,山东济南 250011
  • 折叠

摘要

糖尿病微血管并发症是糖尿病最主要的慢性并发症.研究表明,核转录因子红系2相关因子2/血红素加氧酶-1(Nrf2/HO-1)信号通路是治疗糖尿病微血管并发症的重要靶点.黄酮、黄酮醇、二氢黄酮、异黄酮、二氢异黄酮、查耳酮、黄烷醇、花青素等黄酮类中药单体可以通过调控Nrf2/HO-1信号通路发挥缓解氧化应激、减少炎症反应、抑制细胞凋亡、减轻纤维化、改善血流动力学等作用,从而达到治疗糖尿病视网膜病变、糖尿病心肌病、糖尿病肾病、糖尿病周围神经病变等多种糖尿病微血管并发症的目的.参考文献66篇.

Abstract

Diabetic microangiopathy is the most important chronic complication of diabetes mellitus(DM).Studies have shown that nuclear factor-erythroid 2-related factor 2/heme oxygenase-1(Nrf2/HO-1)signaling pathway is an important target for the treatment of diabetic microangiopathy.Flavonoids,flavonols,dihydro-flavonoids,isoflavones,dihydroisoflavones,chalcones,flavanols,anthocyanins and other flavonoid monomers of Chinese materia medica can alleviate oxidative stress,reduce inflammatory response,inhibit apoptosis,alleviate fibrosis and improve hemodynamics,etc.by regulating Nrf2/HO-l signaling pathway,so as to achieve the purpose of treating diabetic retinopathy,diabetic cardiomyopathy,diabetic nephropathy,diabetic peri-pheral neuropathy and other diabetic microvascular complications.There are 66 references in total.

关键词

糖尿病微血管并发症/核转录因子红系2相关因子2/血红素加氧酶-1信号通路/黄酮类中药单体/氧化应激/炎症反应/细胞凋亡/纤维化/血流动力学

Key words

diabetic microangiopathy/nuclear factor-erythroid 2-related factor 2/heme oxygenase-1 signaling pathway/flavonoid monomer of Chinese materia medica/oxidative stress/inflammatory response/apoptosis/fibrosis/hemodynamics

引用本文复制引用

基金项目

国家自然科学基金青年科学基金(82104727)

山东省自然科学基金(ZR2021MH088)

出版年

2024
山东中医药大学学报
山东中医药大学

山东中医药大学学报

CSTPCD
影响因子:0.52
ISSN:1007-659X
参考文献量66
段落导航相关论文